A detailed history of Assenagon Asset Management S.A. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 31,305 shares of CRL stock, worth $5.32 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,305
Previous 49,030 36.15%
Holding current value
$5.32 Million
Previous $9.66 Million 40.17%
% of portfolio
0.01%
Previous 0.02%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025

SELL
$178.58 - $220.69 $3.17 Million - $3.91 Million
-17,725 Reduced 36.15%
31,305 $5.78 Million
Q3 2024

Oct 23, 2024

BUY
$187.96 - $245.29 $5.57 Million - $7.27 Million
29,621 Added 152.61%
49,030 $9.66 Million
Q2 2024

Jul 18, 2024

SELL
$206.39 - $268.73 $3.89 Million - $5.06 Million
-18,847 Reduced 49.27%
19,409 $4.01 Million
Q1 2024

Apr 24, 2024

BUY
$203.52 - $273.43 $2.6 Million - $3.49 Million
12,769 Added 50.1%
38,256 $10.4 Million
Q4 2023

Jan 17, 2024

SELL
$164.52 - $238.84 $921,970 - $1.34 Million
-5,604 Reduced 18.02%
25,487 $6.03 Million
Q3 2023

Nov 06, 2023

BUY
$194.44 - $217.61 $6.05 Million - $6.77 Million
31,091 New
31,091 $6.09 Million
Q1 2023

Apr 18, 2023

SELL
$191.89 - $259.92 $63,899 - $86,553
-333 Reduced 0.94%
35,017 $7.07 Million
Q4 2022

Jan 12, 2023

SELL
$197.11 - $250.07 $4.97 Million - $6.3 Million
-25,205 Reduced 41.62%
35,350 $7.7 Million
Q3 2022

Oct 27, 2022

BUY
$182.44 - $250.54 $3.39 Million - $4.65 Million
18,561 Added 44.2%
60,555 $11.9 Million
Q2 2022

Jul 27, 2022

BUY
$204.13 - $302.4 $6.97 Million - $10.3 Million
34,153 Added 435.57%
41,994 $8.99 Million
Q1 2022

Apr 25, 2022

SELL
$255.51 - $362.11 $3.21 Million - $4.55 Million
-12,553 Reduced 61.55%
7,841 $2.23 Million
Q4 2021

Feb 01, 2022

SELL
$351.38 - $448.68 $1.47 Million - $1.88 Million
-4,197 Reduced 17.07%
20,394 $7.68 Million
Q3 2021

Oct 19, 2021

SELL
$372.64 - $458.3 $7.33 Million - $9.01 Million
-19,669 Reduced 44.44%
24,591 $10.1 Million
Q2 2021

Jul 15, 2021

SELL
$294.17 - $371.65 $13.1 Million - $16.6 Million
-44,578 Reduced 50.18%
44,260 $16.4 Million
Q1 2021

Apr 26, 2021

BUY
$249.67 - $299.48 $12.8 Million - $15.3 Million
51,144 Added 135.68%
88,838 $25.7 Million
Q4 2020

Feb 01, 2021

SELL
$222.0 - $252.62 $1.17 Million - $1.34 Million
-5,290 Reduced 12.31%
37,694 $9.42 Million
Q3 2020

Oct 07, 2020

BUY
$175.56 - $226.45 $7.55 Million - $9.73 Million
42,984 New
42,984 $9.73 Million
Q3 2019

Oct 16, 2019

SELL
$125.07 - $143.67 $3.02 Million - $3.47 Million
-24,149 Closed
0 $0
Q2 2019

Aug 12, 2019

SELL
$123.4 - $148.55 $38.4 Million - $46.3 Million
-311,470 Reduced 92.8%
24,149 $3.43 Million
Q1 2019

Apr 26, 2019

BUY
$104.82 - $146.73 $27.6 Million - $38.6 Million
262,907 Added 361.57%
335,619 $48.7 Million
Q4 2018

Jan 23, 2019

SELL
$105.09 - $137.23 $34 Million - $44.4 Million
-323,739 Reduced 81.66%
72,712 $8.23 Million
Q3 2018

Oct 29, 2018

BUY
$112.11 - $134.54 $15.1 Million - $18.1 Million
134,594 Added 51.4%
396,451 $53.3 Million
Q2 2018

Jul 17, 2018

BUY
$102.37 - $117.25 $13.3 Million - $15.3 Million
130,325 Added 99.08%
261,857 $29.4 Million
Q1 2018

Apr 30, 2018

BUY
$98.19 - $115.2 $12.9 Million - $15.2 Million
131,532 New
131,532 $14 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.64B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.